Effects of Bevacizumab in Ahmed Glaucoma Valve Surgery”
- Conditions
- glaucoma.GLAUCOMA
- Registration Number
- IRCT2016042527595N1
- Lead Sponsor
- Iran University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
In this randomized clinical trial inclusion criteria are:1-age more than 18 with IOP>21 mmHg with maximal medications ;2- intolerance to medications ;3-history of previous cataract surgery or trabeculectomy with uncontrolled IOP ;4-low success of trabeculectomy due to conjunctival scar .Exclusion criteria are :1-patients with VA NLP; 2-indesirable informed consent ;3-patients who can not be present for follow up; 4-history of previous shunt surgery or CPC; 5-History of SB or Silicone in the eye ;6-Vitreous in AC which need VitX ;7-uveitis ;8- nanophthalmous; 9-struge weber or any disease with increased episcleral pressure ; 10-patients who need adjunct surgery in addition to shunt ;11 -NVG 12-pregnancy or lactating
patients will be enrolled from Radoul Akram Hospital and Central eye clinic and the procedure will be done with same techniques by Dr.Miraftabi and Nilforoushan.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure. Timepoint: Before surgery,1 day ,one week,One month,Three months,6 months and every three month after 6 months. Method of measurement: Goldman applanation tonometry.
- Secondary Outcome Measures
Name Time Method umber of glaucoma medications. Timepoint: Before surgery,1 day ,one week,One month,Three months,6 months and every three month after 6 months. Method of measurement: quantitative.;Postoperative complications. Timepoint: Before surgery,1 day ,one week,One month,Three months,6 months and every three month after 6 months. Method of measurement: qualitative.